Published On: Wed, Oct 19th, 2016

Upgrades And Downgrades For KemPharm, Inc. (KMPH)


Recently stock market analysts have updated their consensus ratings on shares of KemPharm, Inc. (KMPH).

Most recent broker ratings

06/14/2016 – KemPharm, Inc. had its “outperform” rating reiterated by analysts at Oppenheimer. They now have a USD 11 price target on the stock.

05/06/2016 – KemPharm, Inc. had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 14 price target on the stock.

12/16/2015 – KemPharm, Inc. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 34 price target on the stock.

08/14/2015 – KemPharm, Inc. had its “outperform” rating reiterated by analysts at Cowen. They now have a USD 55 price target on the stock.

KemPharm, Inc. has a 50 day moving average of 4.54 and a 200 day moving average of 7.09. The stock’s market capitalization is 60.05M, it has a 52-week low of 3.52 and a 52-week high of 20.60.

The share price of the company (KMPH) was up +7.89% during the last trading session, with a high of 4.20 and the volume of KemPharm, Inc. shares traded was 75302.

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. The Company’s product candidate, KP201/APAP, consists of KP201, its prodrug of hydrocodone, which is combined with acetaminophen (APAP). The Company is developing KP201/APAP as an immediate release (IR), a product candidate for the short-term, or no longer than 14 days for the management of acute pain. The Company has designed KP201/APAP with abuse-deterrent properties to address the epidemic of opioid abuse in the United States. The Company also focuses on developing the pipeline of additional prodrug product candidates that targets pain and attention deficit hyperactivity disorder (ADHD). The Company’s products include KP201/IR (APAP-free), KP511/ER, KP415, KP606/IR and KP746.